We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
Turnover
51.11%
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
+$1.26B
(+86%)
Cap. Flow
-$390M
Cap. Flow
% of AUM
-14.37%
Top 10 Holdings %
Top 10 Hldgs %
63.11%
Holding
138
New
54
Increased
15
Reduced
11
Closed
39
Avg Time Held Equity + Options
0.2
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$109M |
| 2 |
Amgen
AMGN
|
+$53.5M |
| 3 |
CELG
Celgene Corp
CELG
|
+$30.6M |
| 4 |
FDC
First Data Corporation
FDC
|
+$27.3M |
| 5 |
Truist Financial
TFC
|
+$23.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$62.5M |
| 2 |
SHPG
Shire pic
SHPG
|
+$38M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$36.9M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$33.7M |
| 5 |
SEND
SendGrid, Inc.
SEND
|
+$28.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 78.7% |
| 2 | Healthcare | 7.97% |
| 3 | Technology | 6.1% |
| 4 | Communication Services | 2.23% |
| 5 | Financials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Entegris
ENTG
$21.2B
| $535K | 0.02% |
+15,000
| New | +$500K |
2019 Q1
0 quarters
|
|
77
CALL
Novavax
NVAX
$1.86B
| $531K | 0.02% |
48,205
+36,390
| +308% | +$1.15M |
2018 Q4
1 quarter
|
|
78
DELISTED
Chesapeake Energy Corporation
CHK
| $308K | 0.01% |
+496
| New | +$278K |
2019 Q1
0 quarters
|
|
79
Option Care Health
OPCH
$4.67B
| $300K | 0.01% |
+37,500
| New | +$493K |
2019 Q1
0 quarters
|
|
|
GCVRZ
80
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $293K | 0.01% |
644,000
+43,207
| +7% | +$20.2K |
2018 Q3
2 quarters
|
|
81
CALL
DELISTED
Entera Bio Ltd. Warrant
ENTXW
| $279K | 0.01% |
+310,023
| New | +$280K |
2019 Q1
0 quarters
|
|
82
CALL
DELISTED
Immunogen Inc
IMGN
| $270K | 0.01% |
+100,000
| New | +$433K |
2019 Q1
0 quarters
|
|
83
Actinium Pharmaceuticals
ATNM
$35.5M
| $68K | ﹤0.01% |
4,689
-39,057
| -89% | -$624K |
2018 Q1
4 quarters
|
|
84
CALL
DELISTED
Kineta, Inc. Common Stock
KA
| $64K | ﹤0.01% |
+357
| New | +$175K |
2019 Q1
0 quarters
|
|
85
PUT
Cleveland-Cliffs
CLF
$6.91B
| – | – |
-91,800
| Closed | -$707K | – |
|
86
PUT
Walt Disney
DIS
$191B
| – | – |
-176,000
| Closed | -$19.3M | – |
|
87
Genworth Financial
GNW
$3.43B
| – | – |
-805,894
| Closed | -$3.75M | – |
|
88
CALL
Nabors Industries
NBR
$1.19B
| – | – |
-5,770
| Closed | -$571K | – |
|
89
CALL
Royal Gold
RGLD
$20.2B
| – | – |
-14,000
| Closed | -$1.2M | – |
|
90
ProShares Short Russell2000
RWM
$145M
| – | – |
-4,500
| Closed | -$210K | – |
|
91
PUT
Sarepta Therapeutics
SRPT
$1.81B
| – | – |
-38,800
| Closed | -$4.24M | – |
|
92
Under Armour
UAA
$2.04B
| – | – |
-150,000
| Closed | -$2.65M | – |
|
93
CALL
Weibo
WB
$1.59B
| – | – |
-31,500
| Closed | -$1.84M | – |
|
|
94
Weibo
WB
$1.59B
| – | – |
-57,300
| Closed | -$3.35M | – |
|
|
RAD
95
DELISTED
Rite Aid Corporation
RAD
| – | – |
-35,000
| Closed | -$496K | – |
|
|
ACOR
96
PUT
DELISTED
Acorda Therapeutics
ACOR
| – | – |
-1,831
| Closed | -$3.42M | – |
|
|
IMMU
97
CALL
DELISTED
Immunomedics Inc
IMMU
| – | – |
-2,842,400
| Closed | -$40.6M | – |
|
|
IMMU
98
PUT
DELISTED
Immunomedics Inc
IMMU
| – | – |
-3,453,700
| Closed | -$49.3M | – |
|
|
WFT
99
CALL
DELISTED
Weatherford International plc
WFT
| – | – |
-62,500
| Closed | -$35K | – |
|
|
WFT
100
PUT
DELISTED
Weatherford International plc
WFT
| – | – |
-136,000
| Closed | -$76K | – |
|
Similar funds
FFM
AWA
SC
HCM
NB
WFA
RIM
AU
DLD Asset Management's Q1 2019 Portfolio in Review
As of Q1 2019, DLD Asset Management held 138 positions worth $2.72B, up 86% from $1.46B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
DLD Asset Management withdrew a net $390M in Q1 2019, closing 39 positions and reducing 11 holdings. Its most notable exit was Shire pic, an estimated $38M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, up from 67% a quarter earlier, followed by Healthcare and Technology.
Against the trend, DLD Asset Management opened a new position in Biogen worth $82M.
- DLD Asset Management's largest Q1 2019 buy was Biogen: 346,700 shares worth $82M.
- DLD Asset Management added most to L3 Technologies, Inc. in Q1 2019, an estimated $9.9M increase.
- DLD Asset Management's biggest Q1 2019 reduction was Qualcomm, cutting an estimated $62.5M.
- DLD Asset Management fully exited Shire pic in Q1 2019, selling an estimated $38M.
- DLD Asset Management's ten largest holdings make up 63% of its $2.72B portfolio in Q1 2019.
- DLD Asset Management opened 54 new positions and closed 39 in Q1 2019.
- DLD Asset Management's portfolio value rose 86% quarter-over-quarter to $2.72B.
Based on DLD Asset Management's 13F filing for Q1 2019, filed 14 May 2019.